The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Launched by YALE UNIVERSITY · Oct 1, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring the potential benefits of a substance called DMT, along with therapy, for people struggling with Alcohol Use Disorder (AUD). AUD is a medical condition where individuals have difficulty controlling their drinking, which can lead to serious health problems. The study will be conducted in a controlled setting where some participants will receive DMT combined with therapy, while others will receive a placebo, which is a treatment that looks like the real medication but has no active ingredients. This is done to see if DMT really helps improve the condition.

To be eligible for this trial, participants must be between the ages of 18 and 65 and have a diagnosis of Alcohol Use Disorder. They should be in good health and able to give their consent to participate. However, individuals with unstable medical conditions will not be able to join the study. While the trial is not yet recruiting, those who participate can expect to receive careful support and monitoring throughout the study to ensure their safety and well-being. This is an important step in understanding new ways to help people with alcohol-related issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) diagnosis of Alcohol Use Disorder
• • Medically healthy
• • Ability to provide consent
• Exclusion Criteria:
• • Unstable medical conditions